12-17-2014, 12:00 AM
Losses in revenue for major pharmaceutical companies will be tremendous, with projections showing the pharmaceutical industry will lose upwards to $127 billion in brand spending by 2016 due to patent expiration and cheaper generics in the market.
See more at: http://triplehelixblog.com/2014/07/the- ... DtTfC.dpuf
At present, drug companies are forced to sell drugs to Medicaid at the lowest price they charge private insurance plans — or at a 23.1-percent discount from the average price. Extending the provision to Medicare would deprive pharmaceutical companies of $123 billion.
http://www.forbes.com/sites/sallypipes/ ... -industry/
See more at: http://triplehelixblog.com/2014/07/the- ... DtTfC.dpuf
At present, drug companies are forced to sell drugs to Medicaid at the lowest price they charge private insurance plans — or at a 23.1-percent discount from the average price. Extending the provision to Medicare would deprive pharmaceutical companies of $123 billion.
http://www.forbes.com/sites/sallypipes/ ... -industry/